Article
A novel type I factor X variant (factor X Cys350Phe) due to loss of a disulfide bond in the catalytic domain.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis - 1 Jun 2003
Vianello Fabrizio, Lombardi Anna Maria, Bello Federico Dal, Palù Giorgio, Zanon Ezio, Girolami Antonio
Abstract excerpt
We report a novel mutation within the coagulation factor X (FX) that we have designated FX Padua 4. The phenotype and genotype of the proband and family members were studied. The proband was a child affected by a complex neurological syndrome who, after birth, experienced severe bleeding. The proband showed a laboratory pattern characterized by a severe reduction of FX activity and FX antigen, suggesting a true...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
